Company page
Hls Therapeutics, Inc.
HLS Therapeutics, Inc. is a publicly traded company on the Canadian market under the ticker HLS. The company has a market capitalization of approximately CAD 91.3 million. HLS Therapeutics focuses on developing and commercializing innovative pharmaceutical products.
- Ticker
- HLS:TSX
- Asset type
- Stock
- Market cap
- $82.6M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- TSX
- Currency
- CAD